Jezela-Stanek A, Ciara E, Malunowicz E M, Korniszewski L, Piekutowska-Abramczuk D, Popowska E, Krajewska-Walasek M
Department of Medical Genetics, The Children's Memorial Health Institute, Warsaw, Poland.
Eur J Med Genet. 2008 Mar-Apr;51(2):124-40. doi: 10.1016/j.ejmg.2007.11.004. Epub 2007 Dec 8.
Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive disorder caused by reduced activity of 7-dehydrocholesterol reductase, resulting in an increased concentrations of 7-dehydrocholesterol and 8-dehydrocholesterol in body fluids and tissues. Phenotypically it is characterized by wide range of abnormalities, from mild to lethal forms what causes difficulties in its clinical diagnostics. To further delineate the physical spectrum of the mild form of Smith-Lemli-Opitz syndrome, especially with regard to genotype-phenotype correlation, we describe 5 Polish patients with mild phenotype (one with novel mutation in DHCR7 gene and four published before) and analyze 18 other cases from the literature. As the conclusion we give recommendation for tests toward SLOS in cases with "idiopathic" intellectual impairment and/or behavioral anomalies, as well as in biochemically doubtful but clinically fitting cases with overall gestalt and history of this syndrome.
史密斯-利姆利-奥皮茨综合征(SLOS)是一种常染色体隐性疾病,由7-脱氢胆固醇还原酶活性降低引起,导致体液和组织中7-脱氢胆固醇和8-脱氢胆固醇浓度升高。其表型特征为广泛的异常,从轻度到致命形式,这给临床诊断带来困难。为了进一步描述史密斯-利姆利-奥皮茨综合征轻度形式的身体特征谱,特别是关于基因型-表型相关性,我们描述了5例波兰轻度表型患者(1例DHCR7基因有新突变,4例之前已发表),并分析了文献中的其他18例病例。作为结论,我们建议对有“特发性”智力障碍和/或行为异常的病例,以及对整体形态和该综合征病史在生化方面可疑但临床符合的病例进行SLOS检测。